Alzheimer's and seizures: Interleukin-18, indoleamine 2,3-dioxygenase and quinolinic acid

International Journal of Tryptophan Research

Volumn 3, Issue 1, 2010, Pages 169-173

  Anderson, G ^a   Ojala, J O ^b  

^a CRC   (United Kingdom)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alzheimer's; Astrocytes; IDO; IL 18; Losartan; Melatonin; Microglia; Seizures

Indexed keywords

EID: 79954585088     PISSN: None     EISSN: 11786469     Source Type: Journal    
DOI: 10.4137/IJTR.S4603     Document Type: Article

References (41)

1. Palop JJ, Mucke L. Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol. 2009 Apr;66(4):435-40.
2. Palop JJ, Chin J, Roberson ED, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron. 2007 Sep 6;55(5):697-711.
3. Scarmeas N, Honig LS, Choi H, et al. Seizures in Alzheimer disease: who, when, and how common? Arch Neurol. 2009 Aug;66(8):992-7.
4. Fernandes AM, Landeira-Fernandez AM, Souza-Santos P, Carvalho-Alves PC, Castilho RF. Quinolinate-induced rat striatal excitotoxicity impairs endoplasmic reticulum Ca2 ± ATPase function. Neurochem Res. 2008 Sep;33(9):1749-58.
5. de Oliveira DL, Horn JF, Rodrigues JM, et al. Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine. Brain Res. 2004 Aug 20;1018(1):48-54.
6. Jürgens B, Hainz U, Fuchs D, Felzmann T, Heitger A. Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood. 2009 Oct 8;114(15):3235-43.
7. O'Connor JC, André C, Wang Y, et al. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmett-Guerin. J Neurosci. 2009 Apr 1;29(13):4200-9.
8. Belladonna ML, Orabona C, Grohmann U, Puccetti P. TGF-beta and kynurenines as the key to infectious tolerance. Trends Mol Med. 2009 Feb;15(2):41-9.
9. Sekiyama A, Ueda H, Kashiwamura S, et al. IL-18; a cytokine translates a stress into medical science. J Med Invest. 2005 Nov;52 Suppl:236-9.
10. Sugama S, Conti B. Interleukin-18 and stress. Brain Res Rev. 2008 Jun;58(1): 85-95.
11. Gillespie MT, Horwood NJ. Interleukin-18: perspectives on the newest interleukin. Cytokine Growth Factor Rev. 1998 Jun;9(2):109-16.
12. Chakraborty S, Kaushik DK, Gupta M, Basu A. Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res. 2010 Jun;88(8):1615-31.
13. Ojala JO, Sutinen EM, Salminen A, Pirttilä T. Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells. J Neuroimmunol. 2008 Dec 15;205(1-2):86-93.
14. Ojala J, Alafuzoff I, Herukka SK, van Groen T, Tanila H, Pirttilä T. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Neurobiol Aging. 2009 Feb;30(2):198-209.
15. Yu JT, Tan L, Song JH, et al. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Brain Res. 2009 Feb 9;1253:169-75.
16. Briellmann RS, Torn-Broers Y, Busuttil BE, et al. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy Neurology. 2000 Aug 8;55(3):435-7.
17. Hernández F, Gómez de Barreda E, Fuster-Matanzo A, Lucas JJ, Avila J. GSK3: A possible link between beta amyloid peptide and tau protein. Exp Neurol. 2009 (In Press: Online Sep 24).
18. Yamada A, Akimoto H, Kagawa S, Guillemin GJ, Takikawa O. Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2, 3-dioxygenase in monocytic cells primed with amyloid beta peptide 1-42: implications for the pathogenesis Alzheimer's disease. J Neurochem. 2009 Aug;110(3):791-800.
19. Giri RK, Selvaraj SK, Kalra VK. Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA. J Immunol. 2003 May 15;170(10):5281-94.
20. Yuskaitis CJ, Jope RS. Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal. 2009 Feb;21(2):264-73.
21. Cuschieri J, Maier RV. Oxidative stress, lipid rafts, and macrophage reprogramming. Antioxid Redox Signal. 2007 Sep;9(9):1485-97.
22. Sigal N, Gorzalczany Y, Pick E. Two pathways of activation of the superoxide-generating NADPH oxidase of phagocytes in vitro-distinctive effects of inhibitors. Inflammation. 2003 Jun;27(3):147-59.
23. Vivancos M, Moreno JJ. Effect of resveratrol, tyrosol and beta-sitosterol on oxidised low-density lipoprotein-stimulated oxidative stress, arachidonic acid release and prostaglandin E2 synthesis by RAW 264.7 macrophages. Br J Nutr. 2008 Jun;99(6):1199-207.
24. Zhou J, Zhang S, Zhao X, Wei T. Melatonin impairs NADPH oxidase assembly and decreases superoxide anion production in microglia exposed to amyloid-beta1-42. J Pineal Res. 2008 Sep;45(2):157-65.
25. Liebau C, Baltzer AW, Schmidt S, et al. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma. Anticancer Res. 2002 Mar-Apr;22(2A):931-6.
26. Ojala JO, Anderson G. Unpublished results.
27. Jaeger LB, Dohgu S, Sultana R, et al. Lipopolysaccharide alters the bloodbrain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav Immun. 2009 May;23(4):507-17.
28. Owe-Young R, Webster NL, Mukhtar M, et al. Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity. J Neurochem. 2008 May;105(4):1346-57.
29. Zmarowski A, Wu HQ, Brooks JM, et al. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release. Eur J Neurosci. 2009 Feb;29(3):529-38.
30. Saper CB. The dance of the perivascular and endothelial cells: mechanisms of brain response to immune signalling. Neuron. 2010 Jan 14;65(1):4-6.
31. Watanabe T, Suzuki J, Yamawaki H, Sharma VK, Sheu S, Berk B. Losartan Metabolite EXP3179 Activates Akt and Endothelial Nitric Oxide Synthase via Vascular Endothelial Growth Factor Receptor-2 in Endothelial Cells: Angiotensin II Type 1 Receptor-Independent Effects of EXP3179. Circulation. 2005 Sep 20;112(12):1798-805
32. Patel NS, Mathura VS, Bachmeier C, et al. Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2. J Neurochem. In Press (Available online 2009 Oct 10).
33. Maurizi CP. Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal fluid deficiency of melatonin. Med Hypotheses. 2001 Aug;57(2):156-60.
34. Orduña MT, Gabalda CP, Hortensi JV, Pallàs Lliberia M, Espuny AC. An evaluation of the neuroprotective effects of melatonin in an in vitro experimental model of age-induced neuronal apoptosis. J Pineal Res. 2009 Apr;46(3):262-7.
35. Solmaz I, Gürkanlar D, Gökçil Z, Göksoy C, Ozkan M, Erdoǧan E. Antiepileptic activity of melatonin in guinea pigs with pentylenetetrazol-induced seizures. Neurol Res. 2009 Nov;31(9):989-95.
36. Chang HM, Wu UI, Lan CT. Melatonin preserves longevity protein (sirtuin 1) expression in the hippocampus of total sleep-deprived rats. J Pineal Res. 2009 Oct;47(3):211-20.
37. Raskind MA, Burke BL, Crites NJ, Tapp AM, Rasmussen DD. Olanzapineinduced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats. Neuropsychopharmacology. 2007 Feb;32(2):284-8.
38. López A, García JA, Escames G, et al. Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res. 2009 Mar;46(2):188-98.
39. Han Q, Cai T, Tagle DA, Li J. Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Cell Mol Life Sci. 2010 Feb;67(3):353-68.
40. Liu YJ, Zhuang J, Zhu HY, Shen YX, Tan ZL, Zhou JN. Cultured rat cortical astrocytes synthesize melatonin: absence of a diurnal rhythm. J Pineal Res. 2007 Oct;43(3):232-8.
41. Li ZQ, Liang GB, Xue YX, Liu YH. Effects of combination treatment of dexamethasone and melatonin on brain injury in intracerebral hemorrhage model in rats. Brain Res. 2009 Apr 6;1264:98-103.